Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | GMNN | O75496 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | BLM | P54132 | 1/20 | 0.37 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6548556 | 1.00 | TP53 (0.39) | TP53KDM4EGMNNLMNAMAPT | |
| Cyclohexane SCHEMBL5838004 | 1.00 | TP53 (0.39) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL20038792 | 0.97 | — | — | |
| SCHEMBL16792336 | 0.91 | — | — | |
| SCHEMBL1337717 | 0.84 | — | — | |
| SCHEMBL13169085 | 0.82 | TP53 (0.39) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL20354169 | 0.82 | KDM4E (0.42) | TP53KDM4E | |
| SCHEMBL10843765 | 0.79 | KDM4E (0.37) | TP53KDM4ELMNA | |
| SCHEMBL5981075 | 0.78 | TP53 (0.36) | TP53KDM4EGMNNLMNAMAPT | |
| SCHEMBL8137257 | 0.78 | TP53 (0.36) | TP53KDM4EGMNNLMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119710701-A | Chlorine ion resistant medium roughening microetching liquid medicine | 南通群安电子材料有限公司 | 2025-03-28 | — | — | CN | claimed |
| US-6127340-A | ESPCECIALLY THROMBIN, IN WHICH THE P1-P2 NATURAL AMIDE LINKAGE IS REPLACED BY ANOTHER BOND; INHIBITING COAGULATION OF BLOOD IN A CONTAINER; TREATMENT OR PREVENTION OF THROMBOSIS | TRIGEN LIMITED (GB) | 2000-10-03 | — | — | US | claimed |
| WO-1996025427-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1996-08-22 | — | — | WO | claimed |
| CN-121974810-A | Method for preparing dihydroxyethyl cyclohexylamine by autocatalysis | 上海邦高化学有限公司 | 2026-05-05 | — | — | CN | disclosed |
| CN-119019877-B | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119019877-B | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-119019877-A | Inorganic fireproof paint for building and preparation method thereof | 广州市福田化学工业涂料有限公司 | 2024-11-26 | — | — | CN | disclosed |
| CN-117298325-A | Preparation method of calcium-containing polymer hemostatic sponge and sponge preparation device | 中国科学院长春应用化学研究所 | 2023-12-29 | — | — | CN | disclosed |
| WO-2023176641-A1 | TRICYCLODECANEDIMETHANOL COMPOSITION, UV-CURABLE COMPOSITION, POLYMER COMPOSITION, AND TRICYCLODECANEDIMETHANOL COMPOSITION PRODUCTION METHOD | 三菱ケミカル株式会社 | 2023-09-21 | — | — | WO | disclosed |
| CN-109843986-B | Spherical powder comprising crosslinked material having polyrotaxane, and method for producing same | 株式会社ASM | 2022-08-16 | — | — | CN | disclosed |
| CN-108602934-B | Composition for polyurethane foam containing polyrotaxane, polyurethane foam derived from the composition, and method for producing polyurethane foam | 高级软质材料株式会社 | 2021-01-22 | — | — | CN | disclosed |
| US-6437087-B1 | ISOPHTHALIC ACID, UNSATURATED DIACID, HINDERED DIOL, C2-C8 1,2 DIOL, CYCLIC DIOL; UNSATURATED CARBOXY GROUP TERMINATED POLYESTER; LOW VISCOSITY AS WELL AS A SUFFICIENT GLASS TRANSITION TEMPERATURE | BP CORPORATION NORTH AMERICA INC. | 2002-08-20 | — | — | US | disclosed |
| WO-2002034813-A2 | POLYESTER RESIN FOR POWDER COATING | BP CORPORATION NORTH AMERICA INC. (US) | 2002-05-02 | — | — | WO | disclosed |
| US-6127340-A | ESPCECIALLY THROMBIN, IN WHICH THE P1-P2 NATURAL AMIDE LINKAGE IS REPLACED BY ANOTHER BOND; INHIBITING COAGULATION OF BLOOD IN A CONTAINER; TREATMENT OR PREVENTION OF THROMBOSIS | TRIGEN LIMITED (GB) | 2000-10-03 | — | — | US | disclosed |
| EP-0910583-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1999-04-28 | — | — | EP | disclosed |
| WO-1998000443-A1 | THROMBIN INHIBITORS | TRIGEN LIMITED (GB) | 1998-01-08 | — | — | WO | disclosed |
| EP-0809650-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1997-12-03 | — | — | EP | disclosed |
| WO-1996025427-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1996-08-22 | — | — | WO | disclosed |
| US-4184990-A | Process for the preparation of stable dispersions of polyisocyanate-polyaddition products in a hydroxyl containing compound as dispersing agent | BAYER AKTIENGESELLSCHAFT (DE) | 1980-01-22 | — | — | US | disclosed |
| US-4092275-A | Polyurethane resins prepared from active hydrogen containing material which is a dispersion of polyisocyanate-polyaddition products in hydroxyl containing compounds as dispersing agents | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-30 | — | — | US | disclosed |